key: cord-0932946-i5qvgbg3 authors: Adelman, Eric E.; Leppert, Michelle H. title: Neurohospitalist: Inpatient Stroke Care in the Time of COVID-19 date: 2021-04-20 journal: Stroke DOI: 10.1161/strokeaha.121.033557 sha: 55c90be07f1799d8540ff6d5e8956814cd371281 doc_id: 932946 cord_uid: i5qvgbg3 nan T he coronavirus disease (COVID-19) pandemic has transformed inpatient stroke care. Since early 2020, when the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were reported, we have learned a tremendous amount about SARS-CoV-2 infection and its association with stroke. That said, many observations and studies are preliminary, and as vaccination rates increase, the impact of SARS-CoV-2 infection on inpatient stroke care will likely change. We want to highlight some of the major impacts of the COVID-19 pandemic on inpatient stroke care. The pandemic altered the usual multidisciplinary nature of inpatient stroke care. Crowded team rooms moved to socially distanced individual workstations with rounds done via video conference. 1 Bedside teaching rounds were suspended to support social distancing. The robust and interactive cacophony of multidisciplinary stroke rounds was replaced by sterile group telephone calls. Hospitalized patients went without the support of their friends and family as visitors were prohibited, and loved ones coped from afar. Hospital staff filled this void, providing emotional support for both patients and their families. The concern about developing SARS-CoV-2 infection among health professionals caring for stroke patients should not be understated. The high acuity of acute stroke codes and neurological deficits in stroke patients complicated COVID-19 screening in emergency departments. The American Heart Association/American Stroke Association Stroke Council Leadership recommended treating every stroke code patient as potentially infected, which was generally not possible given the initial shortages of appropriate personal protective equipment (PPE) and rapid diagnostic testing. 2 The national PPE shortage put health care workers at risk for SARS-CoV-2 infection, as health care workers with inadequate PPEs had a greater likelihood of infection than their properly protected peers. 3 The PPE crisis highlighted the deep fragmentations of the PPE supply chain and lack of a national, centralized approach. As PPE and rapid testing became available and studies showed decreased rates of hospital, compared with community, transmission 4 caring for patients with SARS-CoV-2 infection and those with pending tests became less stressful for providers. Despite the association of SARS-CoV-2 infection with an increased risk of ischemic stroke, 5 in spring 2020, inpatient stroke volumes decreased. 6 The reasons for this decrease are not completely understood but may relate to patients with stroke symptoms not seeking care due to fear of contracting SARS-CoV-2 in the emergency room, lack of recognition of stroke symptoms due to isolation from social distancing, misdiagnosis of stroke in the setting of SARS-CoV-2 encephalopathy, or other factors. 7 The initial decline in hospitalizations was not isolated to strokes but extended to other acute conditions (eg, myocardial infarctions, urinary tract infections, Stroke. 2021;52:1871-1873. DOI: 10.1161/STROKEAHA.121.033557 Adelman et al Advances in Stroke: Neurohospitalist asthma exacerbations) and resulted in a 42% national decline in emergency room visits during the early pandemic period compared with a year prior. 8 The initial lull in stroke volume allowed centers to develop and implement new processes and protocols to care for stroke patients with SARS-CoV-2 infection with a goal of reducing the duration and frequency staff directly interacted with infectious patients. These changes have the dual benefits of not only reducing staff exposure to potential infection but also helped to conserve PPE. For example, reduced frequency of patient assessments after admission was shown to be safe in a small study. 9 Some hospitals started using tenecteplase, instead of alteplase, for IV thrombolysis because of a simplified workflow that may minimize staff exposure. 10 Most vascular neurologists are familiar with telestroke evaluations for patients at remote sites; however, the pandemic led to the initiation of emergency department and inpatient telestroke evaluations at home institutions. As tertiary care hospitals became crowded with patients infected with SARS-CoV-2, there were many downstream effects. Some stroke providers were reassigned to care for SARS-CoV-2 patients, while in other hospitals, the neurology teams cared for patients on a medicine hospitalist services so the hospitalists could care for the sicker patients. With Comprehensive Stroke Centers at capacity, there was limited availability to transfer patients from regional hospitals. Further research will need to be done to determine how changes to transfer patterns due to the pandemic impacted patient outcomes. Hospital capacity problems were compounded by challenges in getting patients to rehabilitation facilities. Many rehabilitation facilities would not take patients without a negative COVID-19 test, which proved challenging when testing supplies were limited. To help discharge patients with SARS-CoV-2 infection, some states designed specific facilities as COVID only to help address the difficulty in transitioning patients to postacute care. Many states set up field hospitals to help offload capacity at overwhelmed hospitals; however, these facilities were not designed to care for patients with the impaired mobility that affects many patients with stroke. The COVID-19 pandemic highlighted the many care disparities that exist for racial and ethnic minorities in the United States. Preliminary data suggest that Black patients with strokes and SARS-CoV-2 infection have a higher risk of mortality and symptomatic intracranial hemorrhage compared with other patients. 11 These findings are not surprising in the context of racial and ethnic disparities, which are present in stroke care. A recent report highlighted the importance of addressing social determinants of health to reduce these disparities. 12 The COVID-19 pandemic underscores the urgency to address the health care disparities that continue to exist and hamper equitable health outcomes for all Americans. The COVID-19 pandemic has been a stress test of sorts and identified several areas of vulnerability in the current stroke care infrastructure: (1) the fragmented and unreliable PPE supply chain left health care workers at increased risk of infection; (2) inpatient stroke care can be tailored to address unique needs of a pandemic; however, the impact of these changes on patient care will require further study; (3) nationwide racial and ethnic disparities continue to exist and impede equitable health outcomes. Lessons learned from this pandemic will hopefully make stroke care more resilient when future pandemics inevitably arise. Dr Leppert is supported by the NIH Clinical and Translational Science Award (CTSA) grant UL1 KL2 TR002534. Early lessons from world war COVID reinventing our stroke systems of care Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic Coronavirus Pandemic Epidemiology Consortium. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study Quantification of occupational and community risk factors for SARS-CoV-2 seropositivity among health care workers in a large U.S. health care system The impact of SARS-CoV-2 on stroke epidemiology and care: a meta-analysis Collateral effect of Covid-19 on stroke evaluation in the United States Advances in Stroke: Neurohospitalist The curious case of the missing strokes during the COVID-19 pandemic National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 pandemic on emergency department visits -United States Streamlined poststroke treatment order sets during the SARS-CoV-2 pandemic: simplifying while not compromising care Stroke thrombolysis with tenecteplase to reduce emergency department spread of coronavirus disease 2019 and shortages of alteplase Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America Considerations in addressing social determinants of health to reduce racial/ethnic disparities in stroke outcomes in the United States None.